Back to Search Start Over

First translational 'Think Tank' on cerebrovascular disease, cognitive impairment and dementia.

Authors :
Barone, Frank C
Barone, Frank C
Gustafson, Deborah
Crystal, Howard A
Moreno, Herman
Adamski, Mateusz G
Arai, Ken
Baird, Alison E
Balucani, Clotilde
Brickman, Adam M
Cechetto, David
Gorelick, Philip
Biessels, Geert Jan
Kiliaan, Amanda
Launer, Lenore
Schneider, Julie
Sorond, Farzaneh A
Whitmer, Rachel
Wright, Clinton
Zhang, Zheng Gang
Barone, Frank C
Barone, Frank C
Gustafson, Deborah
Crystal, Howard A
Moreno, Herman
Adamski, Mateusz G
Arai, Ken
Baird, Alison E
Balucani, Clotilde
Brickman, Adam M
Cechetto, David
Gorelick, Philip
Biessels, Geert Jan
Kiliaan, Amanda
Launer, Lenore
Schneider, Julie
Sorond, Farzaneh A
Whitmer, Rachel
Wright, Clinton
Zhang, Zheng Gang
Source :
Journal of translational medicine; vol 14, iss 1, 50; 1479-5876
Publication Year :
2016

Abstract

As the human population continues to age, an increasing number of people will exhibit significant deficits in cognitive function and dementia. It is now recognized that cerebrovascular, metabolic and neurodegenerative diseases all play major roles in the evolution of cognitive impairment and dementia. Thus with our more recent recognition of these relationships and our need to understand and more positively impact on this world health problem, "The Leo and Anne Albert Charitable Trust" (Gene Pranzo, Trustee with significant support from Susan Brogan, Meeting Planner) provided generous support for this inaugural international workshop that was held from April 13-16, 2015 at the beautiful Ritz Carlton Golf Resort in North Naples, Florida. Researchers from SUNY Downstate Medical Center, Brooklyn, NY organized the event by selecting the present group of translationally inclined preclinical, clinical and population scientists focused on cerebrovascular disease (CVD) risk and its progression to vascular cognitive impairment (VCI) and dementia. Participants at the workshop addressed important issues related to aging, cognition and dementia by: (1) sharing new data, information and perspectives that intersect vascular, metabolic and neurodegenerative diseases, (2) discussing gaps in translating population risk, clinical and preclinical information to the progression of cognitive loss, and (3) debating new approaches and methods to fill these gaps that can translate into future therapeutic interventions. Participants agreed on topics for group discussion prior to the meeting and focused on specific translational goals that included promoting better understanding of dementia mechanisms, the identification of potential therapeutic targets for intervention, and discussed/debated the potential utility of diagnostic/prognostic markers. Below summarizes the new data-presentations, concepts, novel directions and specific discussion topics addressed by this international translation

Details

Database :
OAIster
Journal :
Journal of translational medicine; vol 14, iss 1, 50; 1479-5876
Notes :
application/pdf, Journal of translational medicine vol 14, iss 1, 50 1479-5876
Publication Type :
Electronic Resource
Accession number :
edsoai.on1391580209
Document Type :
Electronic Resource